Baotou Dongbao Bio-Tech Co Ltd Total Liabilities
Baotou Dongbao Bio-Tech Co Ltd total liabilities. Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has total liabilities worth CN¥831.08 Million CNY (≈ $121.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Baotou Dongbao Bio-Tech Co Ltd (300239) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Baotou Dongbao Bio-Tech Co Ltd (2008–2025)
Total liabilities of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025. This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Baotou Dongbao Bio-Tech Co Ltd (300239) long-term investment share to see how much of total assets are deployed in long-term investments.
Baotou Dongbao Bio-Tech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Star Gas Partners LP
NYSE:SGU
|
USA | $621.24 Million |
|
Norma Group AG NA O.N.
XETRA:NOEJ
|
Germany | €713.83 Million |
|
Pes Camanchaca
SN:CAMANCHACA
|
Chile | CL$423.96 Million |
|
Grupo Traxión S.A.B. de C.V
MX:TRAXIONA
|
Mexico | MX$21.16 Billion |
|
Oculis Holding AG Ordinary shares
NASDAQ:OCS
|
USA | $39.94 Million |
|
Shenyang Chemical Industry Co Ltd
SHE:000698
|
China | CN¥3.74 Billion |
|
Haverty Furniture Companies Inc
NYSE:HVT
|
USA | $345.68 Million |
|
Plaza Retail REIT
TO:PLZ-UN
|
Canada | CA$716.56 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Baotou Dongbao Bio-Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Baotou Dongbao Bio-Tech Co Ltd total assets.
Liquidity & Leverage Metrics
Baotou Dongbao Bio-Tech Co Ltd Total Liabilities Ratios Explained
Baotou Dongbao Bio-Tech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baotou Dongbao Bio-Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)
The table below shows the annual total liabilities of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥826.49 Million ≈ $120.94 Million |
-6.66% |
| 2024-12-31 | CN¥885.50 Million ≈ $129.58 Million |
+4.32% |
| 2023-12-31 | CN¥848.82 Million ≈ $124.21 Million |
+53.70% |
| 2022-12-31 | CN¥552.26 Million ≈ $80.81 Million |
+8.59% |
| 2021-12-31 | CN¥508.58 Million ≈ $74.42 Million |
+21.16% |
| 2020-12-31 | CN¥419.75 Million ≈ $61.42 Million |
+30.16% |
| 2019-12-31 | CN¥322.48 Million ≈ $47.19 Million |
-28.00% |
| 2018-12-31 | CN¥447.86 Million ≈ $65.54 Million |
+85.24% |
| 2017-12-31 | CN¥241.78 Million ≈ $35.38 Million |
+111.58% |
| 2016-12-31 | CN¥114.27 Million ≈ $16.72 Million |
+55.48% |
| 2015-12-31 | CN¥73.50 Million ≈ $10.75 Million |
-61.32% |
| 2014-12-31 | CN¥190.01 Million ≈ $27.80 Million |
+13.00% |
| 2013-12-31 | CN¥168.16 Million ≈ $24.61 Million |
+4.30% |
| 2012-12-31 | CN¥161.23 Million ≈ $23.59 Million |
+97.51% |
| 2011-12-31 | CN¥81.63 Million ≈ $11.95 Million |
-16.38% |
| 2010-12-31 | CN¥97.62 Million ≈ $14.28 Million |
-8.42% |
| 2009-12-31 | CN¥106.60 Million ≈ $15.60 Million |
+4.26% |
| 2008-12-31 | CN¥102.24 Million ≈ $14.96 Million |
-- |
About Baotou Dongbao Bio-Tech Co Ltd
Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen in the People's Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored co… Read more